1)Watson PG, Hayreh SS:Scleritis and episcleritis. Br J Ophthalmol 60:163-191, 1976
2)Watson PG:The nature and the treatment of scleral inflammation. Trans Ophthalmol Soc UK 102:257-281, 1982
3)Ohguro N, Sonoda KH, Takeuchi M et al:The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 56:432-435, 2012
4)Ramenaden ER, Raiji VR:Clinical characteristics and visual outcomes in infectious scleritis. Clin Ophthalmol 7:2113-2122, 2013
5)Rachitskaya A, Mandelcorn ED, Albini TA:An update on the cause and treatment of scleritis. Curr Opin Ophthalmol 21:463-467, 2010
6)Lin P, Bhullar SS, Tessler HH et al:Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol 145:463-471, 2008
7)Jabs DA, Mudun A, Dunn JP:Episcleritis and scleritis:clinical features and treatment results. Am J Ophthalmol 130:469-476, 2000
8)Wakefield D, McCluskey P:Cyclosporin therapy for severe scleritis. Br J Ophthalmol 73:743-746, 1989
9)McCluskey PJ, Watson PG, Lightman S et al:Posterior scleritis:clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106:2380-2386, 1999
10)Sen HN, Sangave AA, Goldstein DA et al:A standardized grading system for scleritis. Ophthalmology 118:768-771, 2011
11)Lachmann SM, Hazleman BL, Watson PG:Scleritis and associated disease. Br Med J 1:88-90, 1978
12)Sadiq Z, Shepherd R, Vardy S:Posterior scleritis—an unusual presentation of facial pain. Br J Oral Maxillofac Surg 41:62-63, 2003